Tenaya Therapeutics picks up $92 mln Series B
South San Francisco-based Tenaya Therapeutics Inc, a provider of curative therapies that target the underlying causes of heart disease, has secured $92 million in Series B financing. Casdin Capital led the round with participation from other investors that included GV and The Column Group.
3 October 2019•1 min read
